Work

Liver Hypertrophy

Year: 2012

Type: article

Source: Toxicologic Pathology

DOI: 10.1177/0192623312448935

Authors: A. P. Hall, C. R. Elcombe, J. R. Foster, T. Harada, W. Kaufmann, A. Knippel, K. Küttler, D. E. Malarkey, R. R. Maronpot, A. Nishikawa, T. Nolte, A. Schulte, V. Strauss, M. J. York

Institutions: AstraZeneca (United Kingdom), The Institute of Environmental Toxicology, Merck KGaA, Darmstadt (Germany), BASF (Germany), National Institutes of Health, National Institute of Environmental Health Sciences, National Institute of Health Sciences, Boehringer Ingelheim (Germany), Federal Institute for Risk Assessment, GlaxoSmithKline (United Kingdom), GlaxoSmithKline Research & Development Limited (United Kingdom)

Language: English

Topic: Drug-Induced Hepatotoxicity and Protection

Subfield: Pharmacology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2096945589

FWCI: 14.08

Cites: 203

Cited by: 427

Related to: 10